Recommendations for reporting tissue and circulating tumour (ct)dna next-generation sequencing results in non-small cell lung cancer

HIGHLIGHTS

• What: This need was highlighted in a 2020 survey which found that oncologists were more confident using single-gene tests than whole-genome or -exome sequencing to make clinical decisions, and the use of multimarker tumour panel tests was regarded as more complicated than single-gene tests, highlighting the need for improved reporting and interpretation of results obtained from multimarker panel tests . In this manuscript, the authors provide recommendations for best practice for the reporting of NGS-based panel testing results in NSCLC.
• Who: Umberto Malapelle from the DepartmentUniversity of of Lung Research and Pulmonary . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.